Selected research
Market Analysis & Forecast
Global Health Product Testing Market Analysis and Forecast 2026-2032
Market perspective
The global Health Product Testing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Health Product Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Health Product Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Health Product Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Health Product Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Health Product Testing include CPT Labs, Bureau Veritas, Eurofins Scientific, ESR, UL (Underwriters Laboratories), Intertek Group, SGS SA, TUV SUD and NSF International, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Health Product Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Health Product Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for Health Product Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Health Product Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Health Product Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Health Product Testing revenue, projected growth trends, production technology, application and end-user industry.
Health Product Testing Segment by Company
CPT Labs
Bureau Veritas
Eurofins Scientific
ESR
UL (Underwriters Laboratories)
Intertek Group
SGS SA
TUV SUD
NSF International
ALS Limited
QIMA (AsiaInspection)
TÜV Rheinland Group
Health Product Testing Segment by Type
Ingredient Testing
Heavy Metal and Hazardous Substance Detection
Microbial Indicator Detection
Physical and Chemical Indicator Monitoring
Toxicology Experiments
Functional Verification
Health Product Testing Segment by Application
Personal
Enterprise
Health Product Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Health Product Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Health Product Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Health Product Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Health Product Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Health Product Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Health Product Testing revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Ingredient Testing
- Heavy Metal and Hazardous Substance Detection
- Microbial Indicator Detection
- Physical and Chemical Indicator Monitoring
- Toxicology Experiments
- Functional Verification
Applications
- Personal
- Enterprise
Companies covered
- CPT Labs
- Bureau Veritas
- Eurofins Scientific
- ESR
- UL (Underwriters Laboratories)
- Intertek Group
- SGS SA
- TUV SUD
- NSF International
- ALS Limited
- QIMA (AsiaInspection)
- TÜV Rheinland Group
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Health Product Testing Market by Type
- 1.2.1 Global Health Product Testing Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Ingredient Testing
- 1.2.3 Heavy Metal and Hazardous Substance Detection
- 1.2.4 Microbial Indicator Detection
- 1.2.5 Physical and Chemical Indicator Monitoring
- 1.2.6 Toxicology Experiments
- 1.2.7 Functional Verification
- 1.3 Health Product Testing Market by Application
- 1.3.1 Global Health Product Testing Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Personal
- 1.3.3 Enterprise
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Health Product Testing Market Dynamics
- 2.1 Health Product Testing Industry Trends
- 2.2 Health Product Testing Industry Drivers
- 2.3 Health Product Testing Industry Opportunities and Challenges
- 2.4 Health Product Testing Industry Restraints
3 Global Growth Perspective
- 3.1 Global Health Product Testing Market Perspective (2021-2032)
- 3.2 Global Health Product Testing Growth Trends by Region
- 3.2.1 Global Health Product Testing Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Health Product Testing Market Size by Region (2021-2026)
- 3.2.3 Global Health Product Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Health Product Testing Revenue by Players
- 4.1.1 Global Health Product Testing Revenue by Players (2021-2026)
- 4.1.2 Global Health Product Testing Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Health Product Testing Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Health Product Testing Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Health Product Testing Key Players Headquarters & Area Served
- 4.4 Global Health Product Testing Players, Product Type & Application
- 4.5 Global Health Product Testing Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Health Product Testing Market CR5 and HHI
- 4.6.3 2025 Health Product Testing Tier 1, Tier 2, and Tier 3
5 Health Product Testing Market Size by Type
- 5.1 Global Health Product Testing Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Health Product Testing Revenue by Type (2021-2032)
- 5.3 Global Health Product Testing Revenue Market Share by Type (2021-2032)
6 Health Product Testing Market Size by Application
- 6.1 Global Health Product Testing Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Health Product Testing Revenue by Application (2021-2032)
- 6.3 Global Health Product Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 CPT Labs
- 7.1.1 CPT Labs Company Information
- 7.1.2 CPT Labs Business Overview
- 7.1.3 CPT Labs Health Product Testing Revenue and Gross Margin (2021-2026)
- 7.1.4 CPT Labs Health Product Testing Product Portfolio
- 7.1.5 CPT Labs Recent Developments
- 7.2 Bureau Veritas
- 7.2.1 Bureau Veritas Company Information
- 7.2.2 Bureau Veritas Business Overview
- 7.2.3 Bureau Veritas Health Product Testing Revenue and Gross Margin (2021-2026)
- 7.2.4 Bureau Veritas Health Product Testing Product Portfolio
- 7.2.5 Bureau Veritas Recent Developments
- 7.3 Eurofins Scientific
- 7.3.1 Eurofins Scientific Company Information
- 7.3.2 Eurofins Scientific Business Overview
- 7.3.3 Eurofins Scientific Health Product Testing Revenue and Gross Margin (2021-2026)
- 7.3.4 Eurofins Scientific Health Product Testing Product Portfolio
- 7.3.5 Eurofins Scientific Recent Developments
- 7.4 ESR
- 7.4.1 ESR Company Information
- 7.4.2 ESR Business Overview
- 7.4.3 ESR Health Product Testing Revenue and Gross Margin (2021-2026)
- 7.4.4 ESR Health Product Testing Product Portfolio
- 7.4.5 ESR Recent Developments
- 7.5 UL (Underwriters Laboratories)
- 7.5.1 UL (Underwriters Laboratories) Company Information
- 7.5.2 UL (Underwriters Laboratories) Business Overview
- 7.5.3 UL (Underwriters Laboratories) Health Product Testing Revenue and Gross Margin (2021-2026)
- 7.5.4 UL (Underwriters Laboratories) Health Product Testing Product Portfolio
- 7.5.5 UL (Underwriters Laboratories) Recent Developments
- 7.6 Intertek Group
- 7.6.1 Intertek Group Company Information
- 7.6.2 Intertek Group Business Overview
- 7.6.3 Intertek Group Health Product Testing Revenue and Gross Margin (2021-2026)
- 7.6.4 Intertek Group Health Product Testing Product Portfolio
- 7.6.5 Intertek Group Recent Developments
- 7.7 SGS SA
- 7.7.1 SGS SA Company Information
- 7.7.2 SGS SA Business Overview
- 7.7.3 SGS SA Health Product Testing Revenue and Gross Margin (2021-2026)
- 7.7.4 SGS SA Health Product Testing Product Portfolio
- 7.7.5 SGS SA Recent Developments
- 7.8 TUV SUD
- 7.8.1 TUV SUD Company Information
- 7.8.2 TUV SUD Business Overview
- 7.8.3 TUV SUD Health Product Testing Revenue and Gross Margin (2021-2026)
- 7.8.4 TUV SUD Health Product Testing Product Portfolio
- 7.8.5 TUV SUD Recent Developments
- 7.9 NSF International
- 7.9.1 NSF International Company Information
- 7.9.2 NSF International Business Overview
- 7.9.3 NSF International Health Product Testing Revenue and Gross Margin (2021-2026)
- 7.9.4 NSF International Health Product Testing Product Portfolio
- 7.9.5 NSF International Recent Developments
- 7.10 ALS Limited
- 7.10.1 ALS Limited Company Information
- 7.10.2 ALS Limited Business Overview
- 7.10.3 ALS Limited Health Product Testing Revenue and Gross Margin (2021-2026)
- 7.10.4 ALS Limited Health Product Testing Product Portfolio
- 7.10.5 ALS Limited Recent Developments
- 7.11 QIMA (AsiaInspection)
- 7.11.1 QIMA (AsiaInspection) Company Information
- 7.11.2 QIMA (AsiaInspection) Business Overview
- 7.11.3 QIMA (AsiaInspection) Health Product Testing Revenue and Gross Margin (2021-2026)
- 7.11.4 QIMA (AsiaInspection) Health Product Testing Product Portfolio
- 7.11.5 QIMA (AsiaInspection) Recent Developments
- 7.12 TÜV Rheinland Group
- 7.12.1 TÜV Rheinland Group Company Information
- 7.12.2 TÜV Rheinland Group Business Overview
- 7.12.3 TÜV Rheinland Group Health Product Testing Revenue and Gross Margin (2021-2026)
- 7.12.4 TÜV Rheinland Group Health Product Testing Product Portfolio
- 7.12.5 TÜV Rheinland Group Recent Developments
8 North America
- 8.1 North America Health Product Testing Revenue (2021-2032)
- 8.2 North America Health Product Testing Revenue by Type (2021-2032)
- 8.2.1 North America Health Product Testing Revenue by Type (2021-2026)
- 8.2.2 North America Health Product Testing Revenue by Type (2027-2032)
- 8.3 North America Health Product Testing Revenue Share by Type (2021-2032)
- 8.4 North America Health Product Testing Revenue by Application (2021-2032)
- 8.4.1 North America Health Product Testing Revenue by Application (2021-2026)
- 8.4.2 North America Health Product Testing Revenue by Application (2027-2032)
- 8.5 North America Health Product Testing Revenue Share by Application (2021-2032)
- 8.6 North America Health Product Testing Revenue by Country
- 8.6.1 North America Health Product Testing Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Health Product Testing Revenue by Country (2021-2026)
- 8.6.3 North America Health Product Testing Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Health Product Testing Revenue (2021-2032)
- 9.2 Europe Health Product Testing Revenue by Type (2021-2032)
- 9.2.1 Europe Health Product Testing Revenue by Type (2021-2026)
- 9.2.2 Europe Health Product Testing Revenue by Type (2027-2032)
- 9.3 Europe Health Product Testing Revenue Share by Type (2021-2032)
- 9.4 Europe Health Product Testing Revenue by Application (2021-2032)
- 9.4.1 Europe Health Product Testing Revenue by Application (2021-2026)
- 9.4.2 Europe Health Product Testing Revenue by Application (2027-2032)
- 9.5 Europe Health Product Testing Revenue Share by Application (2021-2032)
- 9.6 Europe Health Product Testing Revenue by Country
- 9.6.1 Europe Health Product Testing Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Health Product Testing Revenue by Country (2021-2026)
- 9.6.3 Europe Health Product Testing Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Health Product Testing Revenue (2021-2032)
- 10.2 China Health Product Testing Revenue by Type (2021-2032)
- 10.2.1 China Health Product Testing Revenue by Type (2021-2026)
- 10.2.2 China Health Product Testing Revenue by Type (2027-2032)
- 10.3 China Health Product Testing Revenue Share by Type (2021-2032)
- 10.4 China Health Product Testing Revenue by Application (2021-2032)
- 10.4.1 China Health Product Testing Revenue by Application (2021-2026)
- 10.4.2 China Health Product Testing Revenue by Application (2027-2032)
- 10.5 China Health Product Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Health Product Testing Revenue (2021-2032)
- 11.2 Asia Health Product Testing Revenue by Type (2021-2032)
- 11.2.1 Asia Health Product Testing Revenue by Type (2021-2026)
- 11.2.2 Asia Health Product Testing Revenue by Type (2027-2032)
- 11.3 Asia Health Product Testing Revenue Share by Type (2021-2032)
- 11.4 Asia Health Product Testing Revenue by Application (2021-2032)
- 11.4.1 Asia Health Product Testing Revenue by Application (2021-2026)
- 11.4.2 Asia Health Product Testing Revenue by Application (2027-2032)
- 11.5 Asia Health Product Testing Revenue Share by Application (2021-2032)
- 11.6 Asia Health Product Testing Revenue by Country
- 11.6.1 Asia Health Product Testing Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Health Product Testing Revenue by Country (2021-2026)
- 11.6.3 Asia Health Product Testing Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Health Product Testing Revenue (2021-2032)
- 12.2 SAMEA Health Product Testing Revenue by Type (2021-2032)
- 12.2.1 SAMEA Health Product Testing Revenue by Type (2021-2026)
- 12.2.2 SAMEA Health Product Testing Revenue by Type (2027-2032)
- 12.3 SAMEA Health Product Testing Revenue Share by Type (2021-2032)
- 12.4 SAMEA Health Product Testing Revenue by Application (2021-2032)
- 12.4.1 SAMEA Health Product Testing Revenue by Application (2021-2026)
- 12.4.2 SAMEA Health Product Testing Revenue by Application (2027-2032)
- 12.5 SAMEA Health Product Testing Revenue Share by Application (2021-2032)
- 12.6 SAMEA Health Product Testing Revenue by Country
- 12.6.1 SAMEA Health Product Testing Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Health Product Testing Revenue by Country (2021-2026)
- 12.6.3 SAMEA Health Product Testing Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst